EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteostasis modulates gene dosage evolution in antibiotic-resistant bacteria

Chinmaya Jena iD, Saillesh Chinnaraj, Soham Deolankar, Nishad Matange iD

eLife · 2025

DOI: 10.7554/elife.99785 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Chinmaya Jena und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Indian Institute of Science Education and Research, Pune, India. Hauptthemen laut MEDLINE: Escherichia coli, Gene Dosage, Evolution, Molecular, Proteostasis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Wellcome Trust/DBT India Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Evolution of gene expression frequently drives antibiotic resistance in bacteria. We had previously (Patel and Matange, eLife , 2021) shown that, in Escherichia coli , mutations at the mgrB locus were beneficial under trimethoprim exposure and led to overexpression of dihydrofolate reductase (DHFR), encoded by the folA gene. Here, we show that DHFR levels are further enhanced by spontaneous duplication of a genomic segment encompassing folA and spanning hundreds of kilobases. This duplication was rare in wild-type E. coli . However, its frequency was elevated in a lon -knockout strain, altering the mutational landscape early during trimethoprim adaptation. We then exploit this system to investigate the relationship between trimethoprim pressure and folA copy number. During long-term evolution, folA duplications were frequently reversed. Reversal was slower under antibiotic pressure, first requiring the acquisition of point mutations in DHFR or its promoter. Unexpectedly, despite resistance-conferring point mutations, some populations under high trimethoprim pressure maintained folA duplication to compensate for low abundance DHFR mutants. We find that evolution of gene dosage depends on expression demand, which is generated by antibiotic and exacerbated by proteolysis of drug-resistant mutants of DHFR. We propose a novel role for proteostasis as a determinant of copy number evolution in antibiotic-resistant bacteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coliGene DosageEvolution, MolecularProteostasisAnti-Bacterial AgentsDrug Resistance, BacterialTetrahydrofolate DehydrogenaseTrimethoprimEscherichia coli ProteinsGene DuplicationGene Expression Regulation, Bacterial

Stichwörter der Autor:innen

E. coliantimicrobial resistancedihydrofolate reductasegene duplicationgeneticsgenomicsinfectious diseasemicrobiologyproteostasistrimethoprim

Substanzen

Tetrahydrofolate DehydrogenaseTrimethoprimAnti-Bacterial AgentsEscherichia coli Proteins

Autor:innen und Institutionen

  • Department of Biology, Indian Institute of Science Education and Research, Pune, India.

ORCID-Profile: Chinmaya Jena, Nishad Matange

Förderung

  • Wellcome Trust
  • Wellcome Trust/DBT India Alliance

Zitieren

APA

Jena, C., Chinnaraj, S., Deolankar, S., & Matange, N. (2025). Proteostasis modulates gene dosage evolution in antibiotic-resistant bacteria. eLife. https://doi.org/10.7554/elife.99785

Vancouver

Jena C, Chinnaraj S, Deolankar S, Matange N. Proteostasis modulates gene dosage evolution in antibiotic-resistant bacteria. eLife. 2025. doi:10.7554/elife.99785

BibTeX
@article{Jena2025,
  author = {Jena, Chinmaya and Chinnaraj, Saillesh and Deolankar, Soham and Matange, Nishad},
  title = {Proteostasis modulates gene dosage evolution in antibiotic-resistant bacteria},
  journal = {eLife},
  year = {2025},
  doi = {10.7554/elife.99785}
}
Kostenlos starten →